R

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Director – Market Access - BeLux

Growth & MarketingConfirmed live in the last 24 hours
Full-timeRemote in BelgiumNo salary listed

About the Job

Requirements

  • A minimum of 10 years’ experience in market access, pricing, reimbursement, or health economics in pharma or biotech in BeLux.
  • Proven value and benefit assessment experience, with deep understanding of BeLux payer decision-making.
  • Demonstrated success and experience supporting oncology product pre-launch, launch, and post-launch in BeLux.
  • Demonstrated success in negotiating pricing and reimbursement conditions with public administrations and health authorities.
  • Strong stakeholder management and ability to collaborate with internal and external partners.
  • Excellent interpersonal and communication skills.
  • Scientific and solution-oriented mindset and capability to move and execute in a rapidly changing, ambiguous environment.
  • Strong understanding of local healthcare systems, customer dynamics, and reimbursement environments.
  • Experience in a biotech and/or in a build-out.
  • High capacity for social competence for teamwork, coaching, and situational leadership.

Responsibilities

  • Develop and implement strategies to support access and pricing decisions for the RevMed portfolio and launches within the BeLux healthcare system.
  • Lead preparation and submission of value dossiers and benefit assessments, and conduct pricing negotiations with statutory health insurance decision-makers.
  • Partner with regional and local Medical Affairs and Marketing teams to translate clinical and economic evidence into compelling value communications tailored for BeLux payers.
  • Build and maintain relationships with external stakeholders, including payers, HTA authorities, and policy influencers, and represent Revolution Medicines at local trade associations on market access subjects.
  • Work with Midsized Markets and Regional Market Access teams to align local access strategy with broader European and corporate objectives, including alignment of European regulatory strategy and execution with local value dossier submissions and pricing negotiation strategy.
  • Provide early market access input to regional and European clinical development and medical teams.
  • Lead negotiations with all levels of national payers.
  • Develop innovative pricing and value-based contracting models to accelerate reimbursement approvals.
  • Monitor health policy developments, HTA processes, and local reimbursement environments to inform strategy.
  • Represent Market Access in BeLux Leadership Team meetings and contribute to overall business strategy.
  • Drive access- and value-related projects, including landscape assessments, payer market research, payer advisory boards, and guidance on local strategies.
  • Develop outreach and engagement plans for key payers and create and maintain a strong network.
  • Plan early access for new products and indications and drive launch readiness for multiple oncology assets across the portfolio.
  • Influence European and Midsized Markets access strategy based on local payer insights from a leadership position.
  • Travel nationally and internationally.

Desired Qualifications

  • An advanced degree, for example in Life Sciences, Pharmacy, Health Economics, or Public Health.

About the Company

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Redwood City, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Revolution Medicines

See more jobs